Visualitzant Sistema Sanitari Integral d'Utilització Pública de Catalunya - SISCAT per títol
Ara mostrant els elements 2857-2876 d 4315
-
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial)
(American Society of Clinical Oncology, 2022-09-01) -
Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial
(American Society of Clinical Oncology, 2023-01-20) -
Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor
(American Chemical Society, 2022-04-28) -
Overnight switch from levetiracetam to brivaracetam: safety and tolerability
(Elsevier, 2021) -
Oxiürs [fullet]
(Direcció d'Atenció Primària Metropolitana Nord, 2017-06) -
Oxygen Consumption with High-Flow Nasal Oxygen versus Mechanical Ventilation— An International Multicenter Observational Study in COVID–19 Patients (PROXY–COVID)
(American Society of Tropical Medicine and Hygiene, 2023-05) -
p27Kip1 V109G as a biomarker for CDK4/6 inhibitors indication in hormone receptor–positive breast cancer
(Oxford University Press, 2023-04) -
Pain Catastrophizing and Its Relationship with Health Outcomes: Does Pain Intensity Matter?
(Hindawi, 2017-02-28) -
Painful Hemorrhage of Vestibular Papillae: A Probably Underreported Complication of Vestibular Papillomatosis
(International Dermoscopy Society, 2024-01-01) -
Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication
(SAGE Publications, 2019-05-10)